Taxus Cardium Pharmaceuticals Valuation

Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Taxus Cardium Pharma current Real Value cannot be determined due to lack of data. The regular price of Taxus Cardium Pharma is $0.0. Our model measures the value of Taxus Cardium Pharma from inspecting the company fundamentals such as Return On Asset of -2.62, price to book of 3.36 X, and Shares Owned By Insiders of 0.21 % as well as reviewing its technical indicators and probability of bankruptcy.

Taxus Cardium Total Value Analysis

Taxus Cardium Pharmaceuticals is currently anticipated to have valuation of 881.11 K with market capitalization of 64, debt of 1.26 M, and cash on hands of 386.03 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Taxus Cardium fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
881.11 K
64
1.26 M
386.03 K

Taxus Cardium Asset Utilization

One of the ways to look at asset utilization of Taxus is to check how much profit was generated for every dollar of assets it reports. Taxus Cardium Pharma has a negative utilization of assets of -2.62 %, losing $0.0262 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Taxus Cardium Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.

Taxus Cardium Ownership Allocation

Taxus Cardium Pharma shows a total of 64.93 Million outstanding shares. About 99.79 % of Taxus Cardium outstanding shares are held by general public with 0.21 (%) owned by insiders and only 0.0 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Taxus Cardium Profitability Analysis

Net Loss for the year was (517.9 K) with profit before overhead, payroll, taxes, and interest of 0.

Taxus Cardium Growth Indicators

Investing in growth stocks can be very risky. If the company such as Taxus Cardium does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding14.5 M
Retained Earnings-119.4 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Taxus Pink Sheet

If you are still planning to invest in Taxus Cardium Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taxus Cardium's history and understand the potential risks before investing.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios